These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21563246)

  • 1. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
    Chou CT; Chen YL; Wu HK; Chen RC
    J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
    Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
    J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
    Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
    J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
    Kim YK; Kwak HS; Kim CS; Han YM
    J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperintense nodules on non-enhanced T1-weighted gradient-echo magnetic resonance imaging of cirrhotic liver: fate and clinical implications.
    Yu JS; Lee JH; Park MS; Kim KW
    J Magn Reson Imaging; 2006 Sep; 24(3):630-6. PubMed ID: 16888794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR findings of focal eosinophilic liver disease using gadoxetic acid.
    Lee J; Park CM; Kim KA; Lee CH; Choi JW
    Magn Reson Imaging; 2010 Nov; 28(9):1327-34. PubMed ID: 20800984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI.
    Chou CT; Chen RC; Chen WT; Lii JM
    J Chin Med Assoc; 2011 Feb; 74(2):62-8. PubMed ID: 21354082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
    Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
    Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
    J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.
    Denecke T; Steffen IG; Agarwal S; Seehofer D; Kröncke T; Hänninen EL; Kramme IB; Neuhaus P; Saini S; Hamm B; Grieser C
    Eur Radiol; 2012 Aug; 22(8):1769-75. PubMed ID: 22437921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
    Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
    Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
    Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.